Back to Grants
FEDERAL
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
This grant funds biologic-based drug discovery and development for disorders of the nervous system.
About this program
The Blueprint Neurotherapeutics Network (BPN) aims to support the discovery and development of biologic-based therapies for various disorders affecting the nervous system. This initiative is designed for researchers and organizations focused on innovative approaches to treating neurological conditions. By providing funding and resources, the BPN facilitates collaboration among scientists, clinicians, and industry partners to advance therapeutic options for patients in need.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and for-profit companies engaged in drug discovery and development.